Lin Xue X - OmicsDI

Show results for

Unknown (967)
Proteomics (40)
Transcriptomics (14)
Metabolomics (8)
Genomics (4)
Other (1)

Organisms

Homo sapiens (30)
Chlamydomonas reinhardtii (12)
Pseudomonas canadensis (12)
Marchantia polymorpha subsp. ruderalis (12)
Methylocystis sp. (12)
Porites pukoensis (12)
Bothrops insularis (12)
Bothrops jararaca (12)
Bothrops jararacussu (12)
Bothrops cotiara (12)
Streptomyces coelicolor (12)
Pseudomonas taiwanensis (12)
Burkholderia ubonensis MSMB22 (12)
Pseudomonas aeruginosa PA103 (12)
Artibeus jamaicensis (12)
Morchella importuna (12)
Clostridium autoethanogenum (12)
Microbacterium ginsengisoli (12)
Streptomyces sp. A494 Ydz-AH (12)
Shewanella oneidensis MR-1 (12)
Mus musculus (6)
Rattus norvegicus (3)
Trichuris sp. ex Homo sapiens JP-2011 (1)
Takifugu obscurus (1)
Severe acute respiratory syndrome coronavirus 2 (1)
Macaca fascicularis fascicularis (1)
Sus scrofa domesticus (1)
Nicotiana tabacum (1)
Oryza sativa (1)
Arabidopsis thaliana (1)

Organisms

Rattus norvegicus (1)

Repository

iProX (28)
biostudies-arrayexpress (14)
pride (12)
MetaboLights (8)
EGA (2)
geo (1)
GPMDB (1)
ENA (1)

Tissue

Cell culture (2)
Cholangiocarcinoma cell line (1)
Esophageal epithelium (1)
Peritoneal cavity (1)
Mesothelium (1)
Hippocampus (1)
Malignant cell (1)
Blood serum (1)
Blood plasma (1)
Spleen (1)
Leaf (1)
Epithelial cell (1)
T cell (1)

Disease

Not Available (1)
Peritoneal mesothelioma (1)
Esophagus squamous cell carcinoma (1)
Cholangiocarcinoma (1)
Malignant neoplasm of ovary (1)

Technology Type

Mass Spectrometry (12)
Mass spectrometry (8)
Shotgun proteomics (6)
Bottom-up proteomics (5)
SWATH MS (1)
Data-independent acquisition (1)
Data-dependent acquisition (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (5)
Liquid Chromatography MS - negative - reverse phase (4)
Instrument (1)
Liquid Chromatography MS - negative – rp (1)
Liquid Chromatography MS - positive – rp (1)
Agilent 7890 (1)
Xevo G2 QTOF (Waters) (1)

Publication Date

2014 (5)
2026 (5)
2025 (4)
2023 (4)
2022 (4)
2021 (4)
2010 (3)
2024 (3)
2018 (3)
2015 (2)
2012 (2)
2011 (2)
2020 (2)
2019 (2)
2016 (1)
2004 (1)
2017 (1)

CHEBI ID

CHEBI:7916 (4)
CHEBI:28931 (3)
CHEBI:16390 (3)
CHEBI:17781 (3)
CHEBI:24813 (3)
CHEBI:16031 (3)
CHEBI:15746 (3)
CHEBI:28875 (3)
CHEBI:16610 (3)
CHEBI:28842 (3)
CHEBI:16196 (3)
CHEBI:17351 (3)
CHEBI:17013 (3)
CHEBI:55328 (3)
CHEBI:34900 (3)
CHEBI:17927 (3)
CHEBI:16343 (3)
CHEBI:15891 (3)
CHEBI:16704 (3)
CHEBI:16040 (3)
CHEBI:15741 (3)
CHEBI:16235 (3)
CHEBI:186269 (2)
CHEBI:10025 (2)
CHEBI:31550 (2)
CHEBI:15874 (2)
CHEBI:62769 (2)
CHEBI:82512 (2)
CHEBI:31746 (2)
CHEBI:166698 (2)

Metabolite Name

6-Thioinosine-5'-monophosphate (2)
5-Hydroxy-N-formylkynurenine (2)
UDP-glucose (2)
Tiglic acid (2)
1-Oleoylglycerophosphoserine (2)
Orientin (2)
10-Formyldihydrofolate (2)
Fructose (2)
Pristimerin (2)
Isosakuranetin (2)
Spermine (2)
N1-Acetylspermidine (2)
Indoleacetaldehyde (2)
Epothilone B (2)
Dehydroepiandrosterone sulfate (2)
Loganin (2)
7-Methylguanine (2)
Phosphoribosyl-AMP (2)
Xanthurenic acid (2)
Xanthosine (2)
7-Sulfocholic acid (2)
Sphinganine (2)
Spermidine (2)
Suberic acid (2)
Dodecanedioic acid (2)
Adenine (2)
Guanine (2)
Indolelactic acid (2)
Taurine (2)
Uridine (2)

First Public Date

2014 (1)

Study type

RNA-seq of coding RNA (7)
RNA-seq of non coding RNA (2)
Unknown experiment type (1)
Comparative genomic hybridization by array (1)
Other (1)
Transcription profiling by array (1)
Methylation profiling by high throughput sequencing (1)

Release Date

2025 (185)
2023 (144)
2024 (128)
2022 (128)
2021 (102)
2020 (78)
2019 (39)
2018 (33)
2017 (30)
2014 (22)
2015 (20)
2026 (18)
2016 (17)
2012 (11)
2010 (8)
2011 (7)
2013 (6)
2009 (3)
2007 (2)

Lab affiliation

Run Run Shaw Hospital, Zhejiang University School of Medicine (1)
aCollege of Landscape Architecture of Sichuan Agricultural University, Chengdu, Sichuan Province, PR China (1)
1. Nephrology Department of Guilin No. 924 Hospital, Guangxi Key laboratory of Metabolic Diseases Research, Guilin Key laboratory of Kidney Diseases Research, 541002, Guilin, Guangxi, People’s Republic of China. 2. Clinical Medical Research Center, the Second Clinical Medical College of Jinan University (Shenzhen People’s Hospital), 518020, Shenzhen, Guangdong, People’s Republic of China. (1)
Department of Clinical Laboratory, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, China. (1)
BGI-Shenzhen,China (1)
Xuanwu Hospital, Capital Medical University (1)
Department of Microbiology & Immunology, 2the Cancer Center, Medical College of Wisconsin Department of Medicine, Medical College of Wisconsin, Milwaukee, WI (1)
Department of Neurology, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China (1)
Vancouver Prostate Centre (1)
Air Force Medical University (1)
Women’s Reproductive Health Laboratory of Zhejiang Province, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310006, China (1)
Xiamen University (1)

Tags

xref:PubMed:15150374 (1)

Previous page
1 / 104
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 104
Next page

Sort by:

Relevance

Page size

Sheng Xue Ning as a Novel Agent that Promotes SCF-Driven Hematopoietic Stem/Progenitor Cell Proliferation to Promote Erythropoiesis.

Not available

S-EPMC11429878 | biostudies-literature

The analgesic effects of Yu-Xue-Bi tablet (YXB) on mice with inflammatory pain by regulating LXA4-FPR2-TRPA1 pathway.

Not available

S-EPMC11302111 | biostudies-literature

Liver X Receptor Agonism Sensitizes a Subset of Hepatocellular Carcinoma to Sorafenib by Dual-Inhibiting MET and EGFR.

Not available

S-EPMC6911865 | biostudies-literature

Regulatory Role of the VCL/ICAM-1 Pathway in Inflammatory Exudative Damage to the Gas-Blood Barrier in SARS-CoV-2 Infection: New Insights from the Omicron Paradigm

Infections by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), ranging from the initial Wildtype (WT) variant in Wuhan, China, to later variants including Omicron, have showcased a diverse spectrum of symptoms. This diversity underscores the need for ongoing exploration into the vir...

ORGANISM(S): Homo sapiens (Human)

2025-05-07 | PXD054443 | Pride

proteomics analysis using Ethoxzolamide in RKO cells

This study employs quantitative proteomics to investigate the global protein expression changes in human colorectal carcinoma RKO cells induced by treatment with the compound EZA. Cells were treated with EZA or DMSO (vehicle control) for 24 hours prior to proteomic analysis.

ORGANISM(S): Homo sapiens (Human)

2026-05-20 | PXD074302 | Pride

Human Cancer Lc-ms/ms

UPLC-MS-Based Serum Metabolic Profiling Reveals Potential Biomarkers for Predicting Propofol Responsiveness in Females

Although previous studies have shown that certain factors interfere with the sensitivity of propofol, the mechanisms for interindividual variability in response to propofol remain unclear. This study aimed to screen the metabolites to predict patients' sensitivity to propofol and to identify meta...

2021-09-29 | MTBLS2311 | MetaboLights